OCUPRESS by Novartis is clinical pharmacology carteolol hcl is a nonselective beta-adrenergic blocking agent with associated intrinsic sympathomimetic activity and without significant membrane-stabilizing activity. First approved in 1990.
Drug data last refreshed 16h ago · AI intelligence enriched 4w ago
Ocupress (carteolol HCl) is a nonselective beta-adrenergic blocking agent administered as an ophthalmic solution for reducing intraocular pressure in glaucoma and ocular hypertension. It works by reducing aqueous humor production, achieving a median IOP reduction of 22–25% when dosed topically twice daily. The drug has intrinsic sympathomimetic activity without significant membrane-stabilizing effects.
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating potential team consolidation and transition to generic/value positioning.
CLINICAL PHARMACOLOGY Carteolol HCl is a nonselective beta-adrenergic blocking agent with associated intrinsic sympathomimetic activity and without significant membrane-stabilizing activity. Ocupress (carteolol HCl) reduces normal and elevated intraocular pressure (IOP) whether or not accompanied…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Ocupress offers limited growth opportunity given its LOE-approaching status and zero linked job openings; roles focus on defending market share and optimizing cost rather than expansion. Career mobility on this product is constrained, with team size likely stable or declining as the company transitions to generic/lifecycle management.
Worked on OCUPRESS at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.